Spacelabs Partners with Blue-Zone for Greener, Cleaner Anesthesia Delivery

Spacelabs Partners with Blue-Zone for Greener, Cleaner Anesthesia Delivery

<0> Spacelabs Healthcare, Inc.Virginia OwensMobile: 425-281-9438Office: 425-363-5592 </0>

Spacelabs Healthcare announces a partnership with Blue-Zone Technologies, Ltd., a private Canadian company based outside Toronto, to offer Blue-Zone Technologies' Deltasorb® anesthetic collection service as a solution for hospitals to eliminate the release of harmful halogenated anesthetics, a significant class of pharmaceutical waste into the public environment.

During general surgery, less than five percent of consumed anesthetic gases are actually absorbed by the patient. The remaining 95 percent of these medications, recognized as an occupational health and safety hazard, routinely escape out of the hospitals’ operating rooms as gases into the surrounding communities.

Blue-Zone Technologies has pioneered the collection of these anesthetic gases in Ontario, Canada, and Spacelabs Healthcare is partnering with Blue-Zone to expand this collection service on a global basis. The patented Deltasorb® product captures the exhausted halogenated gases in use today and is the only commercially viable solution that allows for processing of these gases into valuable drugs.

“We recognize the impact anesthetic gases can have on the environment,” said Nicholas Ong, President, Spacelabs Healthcare. “Spacelabs is committed to addressing these environmental pollutants by taking the Deltasorb® technology global.”

“We are very excited to partner with a fine company such as Spacelabs Healthcare,” said Dusanka Filipovic, co-inventor of the technologies, founder and President of Blue-Zone Technologies. “This is a very important first step to solving the serious environmental problem of these harmful emissions all around the globe. Our partnership with Spacelabs will allow us to accelerate the deployment of the Deltasorb® anesthetic collection service worldwide, expanding its reach and enhancing the environmental business and health benefits.”

On visiting Blue-Zone, former Minister of the Environment, Hon. Peter Kent, PC, MP, commented on his website, “It is likely that containment of volatile anesthetics will eventually be made mandatory for all medical facilities.”

The Deltasorb® anesthetic collection service enables “cradle to cradle™” environmental stewardship of the delivery of anesthesia. The technology provides a safe and environmentally friendly way to control the discharge of anesthetic gases.

For more information on the Deltasorb Anesthetic Collection Service or about Blue-Zone Technologies, please visit or . For more information on Spacelabs Healthcare, please visit .

Spacelabs Healthcare, Inc. (), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

Blue-Zone Technologies Ltd. (), a privately owned cleantech-based pharmaceutical corporation,headquartered in Toronto, Canada, has developed globally innovative anesthetic gas collection and processing technologies that allow for safer environment and production of a complete line of medically essential anesthetic drugs. Blue-Zone currently serves hundreds of operating rooms in Ontario with routine collection of discharged anesthetic gases thus enabling hospitals to showcase their green community partnership, reduce greenhouse gas emissions, comply with EPA regulations and Occupational Health & Safety Standards.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.